$90.73
-1.53[-1.66%]
At close: Apr 25
$90.73
0[0.00%]
After Hours: 4:20PM EDT
Blueprint Medicines
(NASDAQ:BPMC)Blueprint Medicines Stock (NASDAQ:BPMC), Earnings Estimates, EPS, and Revenue
Blueprint Medicines reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 2
EPS Estimate
$-1.670
Quarterly Revenue Estimate
$80.3M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$249.4M
Analyze the earnings history of Blueprint Medicines using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/02/2024 | AM | BPMC | Q1 | -$2.15 | -$1.67 | — | — | $63.29M | $80.34M | — | — | Get Alert |
| 02/15/2024 | AM | BPMC | Q4 | -$2.65 | -$2.04 | -$1.82 | 10.78% | $38.78M | $66.64M | $71.96M | 7.98% | Get Alert |
| 10/26/2023 | AM | BPMC | Q3 | -$2.23 | -$2.37 | -$2.20 | 7.17% | $65.98M | $50.40M | $56.57M | 12.23% | Get Alert |
| 08/02/2023 | AM | BPMC | Q2 | -$2.68 | -$2.58 | -$2.19 | 15.12% | $36.55M | $45.00M | $57.57M | 27.93% | Get Alert |
| 05/04/2023 | AM | BPMC | Q1 | -$1.79 | -$2.67 | -$2.15 | 19.48% | $62.73M | $41.96M | $63.29M | 50.83% | Get Alert |
| 02/16/2023 | AM | BPMC | Q4 | -$0.99 | -$2.65 | -$2.65 | 0.00% | $107.02M | $34.43M | $38.78M | 12.64% | Get Alert |
| 11/01/2022 | AM | BPMC | Q3 | -$2.00 | -$2.49 | -$2.23 | 10.44% | $24.19M | $43.37M | $65.98M | 52.13% | Get Alert |
| 08/02/2022 | AM | BPMC | Q2 | -$1.86 | -$2.23 | -$2.68 | -20.18% | $27.30M | $37.24M | $36.55M | -1.86% | Get Alert |
| 05/03/2022 | AM | BPMC | Q1 | -$1.72 | -$1.94 | -$1.79 | 7.73% | $21.58M | $36.65M | $62.73M | 71.16% | Get Alert |
| 02/16/2022 | AM | BPMC | Q4 | -$1.53 | -$1.65 | -$0.99 | 40.00% | $34.11M | $102.69M | $107.02M | 4.22% | Get Alert |
| 10/28/2021 | AM | BPMC | Q3 | $11.16 | -$1.63 | -$2.00 | -22.70% | $745.12M | $42.47M | $24.19M | -43.05% | Get Alert |
| 07/29/2021 | AM | BPMC | Q2 | -$2.28 | -$1.86 | -$1.86 | 0.00% | $8.34M | $19.01M | $27.30M | 43.58% | Get Alert |
| 04/29/2021 | AM | BPMC | Q1 | -$2.11 | -$1.86 | -$1.72 | 7.53% | $6.17M | $17.25M | $21.58M | 25.08% | Get Alert |
| 02/17/2021 | AM | BPMC | Q4 | -$1.35 | -$1.62 | -$1.53 | 5.56% | $51.53M | $29.24M | $34.11M | 16.65% | Get Alert |
| 10/29/2020 | AM | BPMC | Q3 | -$1.93 | $7.72 | $11.16 | 44.56% | $9.14M | $631.57M | $745.12M | 17.98% | Get Alert |
| 07/30/2020 | AM | BPMC | Q2 | -$2.04 | -$2.14 | -$2.28 | -6.54% | $5.11M | $6.60M | $8.34M | 26.41% | Get Alert |
| 05/06/2020 | AM | BPMC | Q1 | -$1.98 | -$2.17 | -$2.11 | 2.76% | $730.00K | $5.44M | $6.17M | 13.36% | Get Alert |
| 02/13/2020 | AM | BPMC | Q4 | -$1.83 | -$1.69 | -$1.35 | — | $1.03M | $26.07M | $51.53M | 97.67% | Get Alert |
| 11/05/2019 | AM | BPMC | Q3 | -$1.66 | -$2.17 | -$1.93 | 11.06% | $1.09M | $2.59M | $9.14M | 252.86% | Get Alert |
FAQ
When is Blueprint Medicines (NASDAQ:BPMC) reporting earnings?
Blueprint Medicines (BPMC) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on February 15, 2024 for Q4.
What were the latest earnings per share (EPS) for Blueprint Medicines (NASDAQ:BPMC)?
The Actual EPS was $-1.82, which beat the estimate of $-2.04.
What were Blueprint Medicines’s (NASDAQ:BPMC) revenues?
The Actual Revenue was $72M, which beat the estimate of $66.6M.
Browse earnings estimates, EPS, and revenue on all stocks.